Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 10 of the 22 sources its claims cite were checked for support.
Abstract
The EPI-CT study found an association between cumulative dose and risk of hematological malignancies in a multinational cohort of 948,174 young individuals exposed to CT examinations.
Overview
CoChat Summary
## TL;DR
This multinational cohort study found a clear dose–response between CT radiation dose to active bone marrow and later hematological malignancies in people scanned before age 22. At an estimated excess relative risk of 1.96 per 100 mGy, the authors estimate about 1–2 radiation-attributable hematological malignancies per 10,000 children receiving a typical CT exam today.
## Key findings
- The analysis included 876,771 individuals with 1,331,896 CT examinations and found 790 hematological malignancies during 6,863,833 person-years of follow-up.
- For all hematological malignancies combined, risk rose with dose; compared with <5 mGy, the RR was 2.66 (95% CI 1.92 to 3.70) for ≥50 mGy, and the ERR was 1.96 per 100 mGy (95% CI 1.10 to 3.12).
- Similar dose-related estimates were reported for subtype groups: lymphoid malignancies ERR/100 mGy 2.01 (95% CI 1.02 to 3.42) and myeloid malignancies + acute leukemia ERR/100 mGy 2.02 (95% CI 0.47 to 4.77).
- The paper estimates an excess absolute risk of 17.7 per 100,000 person-years per 100 mGy, and projects that for 10,000 children examined today at a mean dose of 8 mGy, 1–2 hematological malignancies would be attributable over the subsequent 12 years.
- Risk increased with the number of CT examinations: the continuous analyses reported a 43% increase per examination for hematological malignancies overall, 42% for lymphoid malignancies, and 48% for myeloid malignancies and AL.
## Methods
- Design: Multinational retrospective cohort study (EPI-CT) across nine European countries, using record linkage to cancer and mortality registries; follow-up began 2 years after the first CT.
- Sample/data: 948,174 eligible individuals who had at least one CT before age 22 were identified; after excluding those with <2 years follow-up, the analysis included 876,771 people from 276 hospitals.
- Analysis: Active bone marrow doses were reconstructed from scan body region, patient characteristics, time period, and inferred CT parameters; dose–response was modeled with proportional hazards regression and expressed as ERR per 100 mGy, with sensitivity analyses varying lags, dose summaries, exclusions, and country/SES adjustments.
## Limitations
- The paper states that confounding by indication could not be addressed directly in the full European cohort; this is a stated limitation.
- SES data were available in only four countries (32.3% of the cohort), and information was incomplete across different SES dimensions; this is a stated limitation.
- Individual dose uncertainties were not negligible and could not be fully integrated into the risk analyses; this is a stated limitation.
- Evident from the text: follow-up was short on average (7.8 years), and the authors note that this may limit assessment of modifiers such as age at exposure and time since exposure; this is an evident limitation mentioned in the discussion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 2 Not valid · 6 Not checked · 72 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, our leukemia risk estimate is compatible with those derived in a recent combined analysis of data on individuals exposed before the age of 21 years and ABM dose <100 mGy (ERR/100 mGy 0.84–4.66, depending on leukemia subtype)38.”
§ Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults > Discussion
What the sources say
- Partly supportedcites [38] Little, M. P. et al. Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies. Lancet Haematol. 5, e346–e358 (2018). sourceExperimental — accuracy not yet measured
The Results report fitted relative risks of 1.84 for leukaemia excluding chronic lymphocytic leukaemia and 5.66 for acute lymphoblastic leukaemia at 100 mSv; subtracting 1 gives the cited excess-relative-risk endpoints of 0.84 and 4.66. The Methods (Procedures, Radiation dosimetry) say doses were expressed as equivalent doses in mSv, not absorbed doses in mGy, so the cited dose unit is not established by this paper. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Confounding by indication was, however, evaluated either directly—from a review of medical records—or indirectly—through modeling—in several national EPI-CT cohorts15–17,33,34.”
§ Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults > Discussion
What the sources say
- Not checked — no full text of the sourcecites [15] Krille, L. et al. Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study. Radiat. Environ. Biophys. 54, 1–12 (2015). source
- Not checked — no full text of the sourcecites [16] Journy, N. et al. Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France. Br. J. Cancer 112, 185–193 (2015). source
- Not checked — no full text of the sourcecites [17] Foucault, A. et al. Childhood cancer risks estimates following CT scans: an update of the French CT cohort study. Eur. Radiol. 32, 5491–5498 (2022). source
- Not checked — no full text of the sourcecites [33] Meulepas, J. M. et al. Confounding of the association between radiation exposure from CT scans and risk of leukemia and brain tumors by cancer susceptibility syndromes. J. Radiol. Prot. 36, 953–974 (2016). source
- Supportedcites [34] Berrington de Gonzalez, A. et al. Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions. Br. J. Cancer 114, 388–394 (2016). source
The Abstract (Methods) and Materials and methods describe the UK cohort’s review of radiology records, death certificates and pathology reports to identify conditions or preexisting cancers that could bias the CT–cancer association. This supports the direct medical-record-review part of the multi-citation sentence; the paper need not establish what the other cited cohorts did. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“EPI-CT was designed to address previous methodological criticisms and limitations of similar studies12–16.”
§ Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults > Discussion
What the sources say
- Could not verifycites [12] Pearce, M. S. et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 380, 499–505 (2012). sourceExperimental — accuracy not yet measured
The Introduction discusses criticisms of earlier radiation-risk projections, and the Discussion describes improvements in this paper’s dose estimates. Neither section says that EPI-CT was designed to address methodological criticisms or limitations. A search for “EPI-CT” found no passage about its design. (LLM, conf=0.76)
- Could not verifycites [13] Mathews, J. D. et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. Br. Med. J. 346, f2360 (2013). sourceExperimental — accuracy not yet measured
The Methods and Strengths and limitations sections describe the Australian CT cohort and its limitations, but do not discuss EPI-CT’s design. Searches for “EPI-CT” and for methodological criticisms of similar studies found no passage addressing the claim in our copy; page numbers were unavailable. (LLM, conf=0.75)
- Not checked — no full text of the sourcecites [14] Meulepas, J. M. et al. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J. Natl Cancer Inst. 111, 256–263 (2019). source
- Not checked — no full text of the sourcecites [15] Krille, L. et al. Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study. Radiat. Environ. Biophys. 54, 1–12 (2015). source
- Not checked — no full text of the sourcecites [16] Journy, N. et al. Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France. Br. J. Cancer 112, 185–193 (2015). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lagging doses by 1 year had little effect on the ERR/100 mGy, while a lag of 5 years reduced the risk by slightly less than half for all and for lymphoid malignancies and by two-thirds for myeloid malignancies and AL (Table 5).”
§ Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults > Results > Sensitivity analyses Lagging doses by 1 year had little effect on the ERR/100 mGy, while a lag of 5 years reduced the risk by slightly less than half for all and for lymphoid malignancies and by two-thirds for myeloid malignancies and AL (Table 5). Using the median of all dose realizations had no major impact on risk estimates. Substantial ERR increases were noted when excluding individuals with the highest cumulative doses (99th, 98th and 95th percentiles). Excluding 5 and 10 years of follow-up after the first CT increased the estimated ERR/100 mGy for all hematological and for lymphoid malignancies but decreased it for myeloid malignancies and AL; the confidence interval of the latter included zero with a 10-year exclusion (two-thirds of cases excluded). Restricting analyses to individuals born after cancer registration was established in their country/region led to a 10–20% reduction in the ERR/100 mGy depending on outcome, while excluding individuals with a CT in a hospital with low CT reporting consistency had little impact on the risk estimates, except for myeloid malignancies and AL (25% decrease). Restricting the follow-up to 2 years after the maximum age at first CT in each country reduced the number of cases from 790 to 491 and duration of follow-up and resulted in lower, but still elevated, risk estimates particularly for lymphoid malignancies. Excluding individuals with no vital status (n = 78,793) slightly reduced risk estimates and increased the width of the CIs, due to the reduction in sample size, for all hematological and lymphoid malignancies, and reduced the myeloid malignancies and AL risk estimates by 31%. Analyses excluding individuals known to have undergone transplantation (United Kingdom only) had little effect on the risk estimate for lymphoid malignancies.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The excess absolute risk (EAR) was estimated to be 17.7 per 100,000 PYs per 100 mGy (95% CI 11.6 to 24.0).”
§ Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults > Results > Risk estimation
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 86 claims and every source verdict.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 15
Citations
Cites
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119 · cited 4×
“…to cell lineage and maturation 27,28 , the analyses were conducted using the revised WHO classification of lymphoid and myeloid malignancies 27,28 , focusing on the following groupings, types and subtypes (morphology codes in Supplementary Table 1): • All hematological malignancies,…”
InfluentialComputed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831 · cited 4×
“EPI-CT also evaluated risk using the revised World Health Organization (WHO) classification of hematopoietic and lymphoid tissue malignancies 27,28 .”
InfluentialThe 2007 recommendations of the International Commission on Radiological Protection
Valentin, J. (2007) · Elsevier eBooks · Cited by 4,105
Pearce, M. S., Salotti, J. A., Little, M. P., McHugh, K., Lee, C., Kim, K. P., Howe, N. L., Ronckers, C. M., Rajaraman, P., Craft, A. W., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60815-0 · Cited by 3,735
Self-citationPreface, Executive Summary and Glossary
(2007) · Annals of the ICRP · doi:10.1016/j.icrp.2007.10.003 · Cited by 2,106
Mathews, J. D., Forsythe, A. V., Brady, Z., Butler, M. W., Goergen, S. K., Byrnes, G. B., Giles, G. G., Wallace, A. B., Anderson, P. R., Guiver, T. A., et al. (2013) · BMJ · doi:10.1136/bmj.f2360 · Cited by 2,029 · cited 1×
“Although results of most individual studies 12,13,17,20 and a recent meta-analysis 21 suggest an increased risk of leukemia associated with repeated CT examinations, studies were criticized due to low statistical power, inadequate individual dosimetry and potential bias from confounding by…”
Self-citationHealth Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2
(2006) · National Academies Press eBooks · doi:10.17226/11340 · Cited by 904
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001
Hsu, W.-L., Preston, D. L., Soda, M., Sugiyama, H., Funamoto, S., Kodama, K., Kimura, A., Kamada, N., Dohy, H., Tomonaga, M., et al. (2013) · Radiation Research · doi:10.1667/rr2892.1 · Cited by 409 · cited 2×
“Current international radiological protection recommendations 23 are, therefore, mainly based on linear extrapolations of risk from the higher doses of the Japanese atomic bomb survivor studies 24 .”
Radiation exposure from pediatric CT scans and subsequent cancer risk in The Netherlands
Meulepas, J. M., Ronckers, C. M., Smets, A. M. J. B., Nievelstein, R. A. J., Gradowska, P., Lee, C., Jahnen, A., van Straten, M., de Wit, M.-C. Y., Zonnenberg, B., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy104 · Cited by 360
Research works printed but not linked: 1
- UNSCEAR 2006 Report. Annex A. Epidemiological studies of radiation and cancer. United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations, New York (2006) https://www.unscear.org/unscear/uploads/documents/publications/UNSCEAR_2006_Annex-A-CORR.pdf
Cited by
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
Smith-Bindman, R., Chu, P. W., Azman Firdaus, H., Stewart, C., Malekhedayat, M., Alber, S., Bolch, W. E., Mahendra, M., Berrington de González, A., & Miglioretti, D. L. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.0505 · Cited by 358
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk
Smith‐Bindman, R., Alber, S. A., Kwan, M. L., Pequeno, P., Bolch, W. E., Bowles, E. J. A., Greenlee, R. T., Stout, N. K., Weinmann, S. A., Moy, L. M., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2502098 · Cited by 118
“8,15 31 Thus, reverse causation does not explain our findings.”
Deep learning-based algorithms for low-dose CT imaging: A review
Chen, H., Li, Q., Zhou, L., & Li, F. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111355 · Cited by 80
Environmental pollution and cancer
da Silva, D. B., Pianovski, M. A. D., & Filho, N. P. D. C. (2024) · Jornal de Pediatria · doi:10.1016/j.jped.2024.09.004 · Cited by 71
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Salehjahromi, M., Karpinets, T. V., Sujit, S. J., Qayati, M., Chen, P., Aminu, M., Saad, M. B., Bandyopadhyay, R., Hong, L., Sheshadri, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101463 · Cited by 62
Metadata
- Authors
- Bosch de Basea, M., Thierry-Chef, I., Harbron, R., Hauptmann, M., Byrnes, G., Bernier, M.-O., Le Cornet, L., Dabin, J., Ferro, G., Istad, T. S., Jahnen, A., Lee, C., Maccia, C., Malchair, F., Olerud, H., Simon, S. L., Figuerola, J., Peiro, A., Engels, H., Johansen, C., Blettner, M., Kaijser, M., Kjaerheim, K., Berrington de Gonzalez, A., Journy, N., Meulepas, J. M., Moissonnier, M., Nordenskjold, A., Pokora, R., Ronckers, C., Schüz, J., Kesminiene, A., & Cardis, E.
- Affiliations
- Universitat Pompeu Fabra (ES)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Centre international de recherche sur le cancer (FR)
- Belgian Nuclear Research Centre (BE)
- Norwegian Radiation and Nuclear Safety Authority (NO)
- National Institutes of Health (US)
- Rigshospitalet (DK)
- Johannes Gutenberg University Mainz (DE)
- Karolinska University Hospital (SE)
- Institut de Radioprotection et de Sûreté Nucléaire (FR)
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Cardis, Elisabeth
- ORCID
- Thierry-Chef, Isabelle
- Harbron, Richard
- Hauptmann, Michael
- Byrnes, Graham
- Dabin, Jérémie
- Jahnen, Andreas
- Lee, Choonsik
- Malchair, Françoise
- Olerud, Hilde
- Simon, Steven L.
- Figuerola, Jordi
- Johansen, Christoffer
- Blettner, Maria
- Kaijser, Magnus
- Meulepas, Johanna M.
- Moissonnier, Monika
- Pokora, Roman
- Schüz, Joachim
- Kesminiene, Ausrele
- Cardis, Elisabeth
- Venue
- Nature Medicine
- Published
- 2023-11-09
- Volume
- 29
- Issue
- 12
- Pages
- 3111-3119
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC10719096
- OpenAlex
- W4388523332
- Cited by
- 349
- References
- 37
- Citations by year
- 2026: 115 · 2025: 129 · 2024: 101 · 2023: 4
- FWCI
- 57.53
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-04-11)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- HAL (submittedVersion, cc-by)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- EC | EC Seventh Framework Programm | FP7 Nuclear Fission, Safety and Radiation Protection (269912)
- Given the large number of funders for this project, we have included only the main source of funding above. The list of all funders is shown in the manuscript
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Radioactivity and Radon Measurements
- Keywords
- computed tomography, ionizing radiation exposure, hematologic malignancies, low-dose radiation, lymphoid malignancies, myeloid neoplasms, cumulative radiation dose, dose optimization
- MeSH terms
- Radiation Exposure, Adolescent, Adult, Child, Humans, Neoplasms, Radiation-Induced, Radiation Dosage, Tomography, X-Ray Computed, Hematologic Neoplasms, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. https://app.cochat.ai/papers/10.1038/s41591-023-02620-0
- The paper
- Bosch de Basea, M., Thierry-Chef, I., Harbron, R., Hauptmann, M., Byrnes, G., Bernier, M.-O., Le Cornet, L., Dabin, J., Ferro, G., Istad, T. S., Jahnen, A., Lee, C., Maccia, C., Malchair, F., Olerud, H., Simon, S. L., Figuerola, J., Peiro, A., Engels, H., . . . Cardis, E. (2023). Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nature Medicine. https://doi.org/10.1038/s41591-023-02620-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.